We use cookies and other tools to enhance your experience on our website and to analyze our web traffic.
For more information about these cookies and the data collected, please refer to our Privacy Policy.

Search

ntg1 under Medical History/Medications/SHHS1 in SHHS variables
Participant taking NITRATES within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
pvdl1 under Medical History/Medications/SHHS1 in SHHS variables
Participant taking PERIPHERAL VASODILATORS, EXCLUDE DIPYRIDAMOLE within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
vaso1 under Medical History/Medications/SHHS1 in SHHS variables
Participant taking VASODILATORS, A MIXED GROUP within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
vasod1 under Medical History/Medications/SHHS1 in SHHS variables
Participant taking VASODILATORS WITH DIURETICS, A MIXED GROUP within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
a2a2 under Medical History/Medications/SHHS2 in SHHS variables
Participant taking ANGIOTENSIN TYPE 2 ANTAGONISTS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
a2ad2 under Medical History/Medications/SHHS2 in SHHS variables
Participant taking COMBINATIONS OF ANGIOTENSIN II ANTAGONISTS PLUS DIURETICS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
ace2 under Medical History/Medications/SHHS2 in SHHS variables
Participant taking angiotensin-converting-enzyme inhibitor (ACE) INHIBITORS WITHOUT DIURETICS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
aced2 under Medical History/Medications/SHHS2 in SHHS variables
Participant taking angiotensin-converting-enzyme inhibitor (ACE) INHIBITORS WITH DIURETICS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
alpha2 under Medical History/Medications/SHHS2 in SHHS variables
Participant taking ALPHA-BLOCKERS WITHOUT DIURETICS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
alphad2 under Medical History/Medications/SHHS2 in SHHS variables
Participant taking ALPHA-BLOCKERS WITH DIURETICS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
amlod2 under Medical History/Medications/SHHS2 in SHHS variables
Participant taking AMLODIPINE within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
beta2 under Medical History/Medications/SHHS2 in SHHS variables
Participant taking BETA-BLOCKERS WITHOUT DIURETICS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
betad2 under Medical History/Medications/SHHS2 in SHHS variables
Participant taking BETA-BLOCKERS WITH DIURETICS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
ccb2 under Medical History/Medications/SHHS2 in SHHS variables
Participant taking ANY CALCIUM-CHANNEL BLOCKER = CCIR OR CCBSR OR CCBT within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
ccbir2 under Medical History/Medications/SHHS2 in SHHS variables
Participant taking IMMEDIATE-RELEASE CCBS = NIFIR OR DIHIR OR VERIR OR DLTIR within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
ccbsr2 under Medical History/Medications/SHHS2 in SHHS variables
Participant taking SLOW-RELEASE CCBS = NIFSR OR DIHSR OR VERSR OR DLTSR OR AMLOD within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
ccbt2 under Medical History/Medications/SHHS2 in SHHS variables
Participant taking T-TYPE CALCIUM-CHANNEL BLOCKER within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
dig2 under Medical History/Medications/SHHS2 in SHHS variables
Participant taking DIGITALIS PREPARATIONS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
dihir2 under Medical History/Medications/SHHS2 in SHHS variables
Participant taking IMMEDIATE-RELEASE DIHYDROPYRIDINES OTHER THAN NIFEDIPINE within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
dihsr2 under Medical History/Medications/SHHS2 in SHHS variables
Participant taking SLOW-RELEASE DIHYDROPYRIDINES OTHER THAN NIFEDIPINE OR AMLOPIDINE within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
diur2 under Medical History/Medications/SHHS2 in SHHS variables
Participant taking ANY DIURETIC within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
dltir2 under Medical History/Medications/SHHS2 in SHHS variables
Participant taking IMMEDIATE-RELEASE DILTIAZEM within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
dltsr2 under Medical History/Medications/SHHS2 in SHHS variables
Participant taking SLOW-RELEASE DILTIAZEM within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
hctz2 under Medical History/Medications/SHHS2 in SHHS variables
Participant taking THIAZIDE DIURETICS WITHOUT K-SPARING AGENTS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
hctzk2 under Medical History/Medications/SHHS2 in SHHS variables
Participant taking THIAZIDE DIURETICS WITH K-SPARING AGENTS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.